Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 1;173(2):153-159.
doi: 10.1001/jamapediatrics.2018.4208.

Prevalence and Treatment Patterns of Autism Spectrum Disorder in the United States, 2016

Guifeng Xu  1   2 , Lane Strathearn  2   3 , Buyun Liu  1 , Matthew O'Brien  2 , Todd G Kopelman  4 , Jing Zhu  5 , Linda G Snetselaar  1 , Wei Bao  1
Affiliations

Prevalence and Treatment Patterns of Autism Spectrum Disorder in the United States, 2016

Guifeng Xu et al. JAMA Pediatr. .

Abstract

Importance: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder. Previous surveys have reported a steady increase in ASD prevalence in US children over the past decades. Several behavioral therapies and medications have been developed to treat the symptoms of ASD; however, little is known about the current status of treatment usage for children diagnosed as having ASD.

Objective: To estimate the prevalence and treatment patterns of ASD among US children using nationally representative data.

Design, setting, and participants: This study used data from the 2016 National Survey of Children's Health, a nationwide, population-based, cross-sectional survey. We included 43 032 children aged 3 to 17 years. Data were collected through questionnaires completed by a parent or guardian. Data were analyzed from February 2018 to March 2018.

Main outcomes and measures: Outcome variables included ASD diagnosed by a physician or health professional and the use of behavioral treatment or medication treatment among children with ASD.

Results: Of the 43 032 included participants, 22 072 (51.3%) were male, and the mean (SD) age was 10.7 (4.4) years. The weighted prevalence of ever-diagnosed ASD and current ASD were 2.79% (95% CI, 2.46-3.12) and 2.50% (95% CI, 2.21-2.79), respectively. The state-level prevalence of ever-diagnosed ASD varied from 1.54% (95% CI, 0.60-2.48) in Texas to 4.88% (95% CI, 2.72-7.05) in Florida. Nationally, about 70% of children with current ASD (70.5%; 95% CI, 65.1-75.8) were treated; 43.3% (95% CI, 37.4-49.2) received behavioral treatment only, 6.9% (95% CI, 3.7-10.1) received medication treatment only, and 20.3% (95% CI, 16.5-24.1) received both behavioral and medication treatments. The remaining 29.5% (95% CI, 24.2-34.9) of children with current ASD did not receive either behavioral or medication treatment.

Conclusions and relevance: This study showed that the prevalence of ASD in the United States was relatively high, and it varied substantially across US states. Almost 30% of US children with ASD did not receive behavioral or medication treatment, which calls for a critical need to understand and address the barriers for those children to receive appropriate treatments.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. State-Level Weighted Prevalence of Ever-Diagnosed Autism Spectrum Disorder in the United States, 2016
See this image and copyright information in PMC

References

    1. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910. doi:10.1016/S0140-6736(13)61539-1 - DOI - PubMed
    1. Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses [published online March 17, 2017]. Mol Autism. doi:10.1186/s13229-017-0121-4 - DOI - PMC - PubMed
    1. Geschwind DH, State MW. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 2015;14(11):1109-1120. doi:10.1016/S1474-4422(15)00044-7 - DOI - PMC - PubMed
    1. Lyall K, Croen L, Daniels J, et al. . The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017;38:81-102. doi:10.1146/annurev-publhealth-031816-044318 - DOI - PMC - PubMed
    1. Buescher AV, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 2014;168(8):721-728. doi:10.1001/jamapediatrics.2014.210 - DOI - PubMed

Substances